The nickel enzyme methyl-coenzyme M reductase from methanogenic archaea: in vitro interconversions among the EPR detectable MCR-red1 and MCR-red2 states.
Methyl-coenzyme M reductase (MCR) catalyzes the formation of methane from methyl-coenzyme M and coenzyme B in methanogenic archaea. The enzyme contains tightly bound the nickel porphinoid F430. The nickel enzyme has been shown to be active only when its prosthetic group is in the Ni(I) reduced state. In this state MCR exhibits the nickel-based EPR signal red1. We report here for the MCR from Methanothermobacter marburgensis that the EPR spectrum of the active enzyme changed upon addition or removal of coenzyme M, methyl coenzyme M and/or coenzyme B. In the presence of methyl-coenzyme M the red1 signal showed a more resolved 14N-superhyperfine splitting than in the presence of coenzyme M indicating a possible axial ligation of the substrate to the Ni(I). In the presence of methyl-coenzyme M and coenzyme B the red1 signal was the same as in the presence of methyl-coenzyme M alone. However, in the presence of coenzyme M and coenzyme B a highly rhombic EPR signal, MCR-red2, was induced, which was found to be light sensitive and appeared to be formed at the expense of the MCR-red1 signal. Upon addition of methyl-coenzyme M, the red2 signal disappeared and the red1 signal increased again. The red2 signal of MCR with 61Ni-labeled cofactor was significantly broadened indicating that the signal is nickel or nickel-ligand based.
Mahlert
Felix
F
Max-Planck-Institut für terrestrische Mikrobiologie, Karl-von-Frisch-Strasse, D-35043 Marburg, Germany.
Grabarse
Wolfgang
W
Kahnt
Jörg
J
Thauer
Rudolf K
RK
Duin
Evert C
EC
D004578:Electron Spin Resonance Spectroscopy / Q000379:methods; D004789:Enzyme Activation; D004795:Enzyme Stability / Q000502:physiology; D006859:Hydrogen / Q000378:metabolism; D015080:Mesna / Q000031:analogs & derivatives* / Q000378:metabolism*; D008665:Metalloporphyrins / Q000378:metabolism*; D017014:Methanobacterium / Q000201:enzymology*; D009532:Nickel / Q000494:pharmacology*; D010084:Oxidation-Reduction / Q000187:drug effects; D010088:Oxidoreductases / Q000378:metabolism*; D013057:Spectrum Analysis / Q000379:methods; D014025:Titanium / Q000494:pharmacology
D008665:Metalloporphyrins; C023349:methyl coenzyme M; C023540:factor F430; D009532:Nickel; D006859:Hydrogen; D014025:Titanium; D010088:Oxidoreductases; C021572:methyl coenzyme M reductase; D015080:Mesna